[1]Phytochemistry,1998,vol.47,#8,p.1521-1525
[2]ChemicalandPharmaceuticalBulletin,2004,vol.52,#10,p.1171-1174
[3]BioorganicandMedicinalChemistry,2012,vol.20,#2,p.784-788
[4]BulletindesSocietesChimiquesBelges,1994,vol.103,#7-8,p.405-424
[5]OrganicandBiomolecularChemistry,2006,vol.4,#8,p.1604-1610
[6]JournalofMedicinalChemistry,1992,vol.35,#10,p.1877-1882
[7]BioorganicandMedicinalChemistryLetters,2011,vol.21,#19,p.5770-5773
[8]EuropeanJournalofMedicinalChemistry,2012,vol.57,p.134-142
[9]BioorganicandMedicinalChemistryLetters,2014,vol.24,#19,p.4654-4658
[10]BioorganicandMedicinalChemistryLetters,2017,vol.27,#13,p.2920-2925
[11]JournalofNaturalProducts,2017,vol.80,#6,p.1939-1943
[12]PhytotherapyResearch,2017,vol.31,#9,p.1369-1375
[1]Phytochemistry(Elsevier),1992,vol.31,#4,p.1363-1366
[2]Phytochemistry(Elsevier),1992,vol.31,#4,p.1363-1366
[1]JournalofNaturalProducts,2009,vol.72,#9,p.1702-1704
[1]Phytochemistry,1998,vol.47,p.1521-1525
[2]ChemicalandPharmaceuticalBulletin,2004,vol.52,p.1171-1174
[3]BioorganicandMedicinalChemistry,2012,vol.20,p.784-788
[4]BulletindesSocietesChimiquesBelges,1994,vol.103,p.405-424
[5],2020
[6]OrganicandBiomolecularChemistry,2006,vol.4,p.1604-1610
[7]JournalofMedicinalChemistry,1992,vol.35,p.1877-1882
[8]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.5770-5773
[9]EuropeanJournalofMedicinalChemistry,2012,vol.57,p.134-142
[10]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.4654-4658
[11]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.2920-2925
[12]JournalofNaturalProducts,2017,vol.80,p.1939-1943
[13]PhytotherapyResearch,2017,vol.31,p.1369-1375
[14]EuropeanJournalofMedicinalChemistry,2018,vol.152,p.274-282
[1]ChemicalandPharmaceuticalBulletin,2004,vol.52,p.1171-1174
[2]JournalofMedicinalChemistry,1992,vol.35,p.1877-1882
[3]Tetrahedron,1988,vol.44,p.101-110
[4]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1982,vol.21,p.496-498
[5]Phytochemistry,2004,vol.65,p.3021-3027
[6]Tetrahedron,1988,vol.44,p.101-110
[1]TetrahedronLetters,1987,vol.28,p.2579-2582
[1]AgriculturalandBiologicalChemistry,1987,vol.51,p.419-423
[1]JournalofMedicinalChemistry,1992,vol.35,p.1877-1882
Title: Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Journal: Bioorganic & medicinal chemistry 20121115
Title: Auraptene attenuates gastritis via reduction of Helicobacter pylori colonization and pro-inflammatory mediator production in C57BL/6 mice.
Journal: Journal of medicinal food 20120701
Title: Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist.
Journal: Bioorganic & medicinal chemistry letters 20120501
Title: Novel prodrugs for the treatment of colonic diseases based on 5-aminosalicylic acid, 4'-geranyloxyferulic acid, and auraptene: biological activities and analytical assays.
Journal: Current drug delivery 20120301
Title: Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
Journal: Bioorganic & medicinal chemistry 20120115
Title: Neurotrophic effect of citrus auraptene: neuritogenic activity in PC12 cells.
Journal: International journal of molecular sciences 20120101
Title: Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7.
Journal: International journal of breast cancer 20120101
Title: Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice.
Journal: Molecular nutrition & food research 20111201
Title: Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative.
Journal: Bioorganic & medicinal chemistry letters 20111001
Title: Identification, synthesis and quantification of process-related impurities in auraptene.
Journal: Journal of pharmaceutical and biomedical analysis 20110910
Title: Development of a quantitative bioassay to assess preventive compounds against inflammation-based carcinogenesis.
Journal: Nitric oxide : biology and chemistry 20110801
Title: Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
Journal: Bioorganic & medicinal chemistry letters 20110715
Title: Potential benefits of supplementation with auraptene in cystic fibrosis.
Journal: Clinical nutrition (Edinburgh, Scotland) 20110401
Title: Auraptene: a natural biologically active compound with multiple targets.
Journal: Current drug targets 20110301
Title: Citrus auraptene: a potential multifunctional therapeutic agent for nonalcoholic fatty liver disease.
Journal: Annals of hepatology 20110101
Title: Effects of selected food phytochemicals in reducing the toxic actions of TCDD and p,p'-DDT in U937 macrophages.
Journal: Archives of toxicology 20101201
Title: Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors.
Journal: Molecular pharmacology 20101101
Title: Anti-human immunodeficiency virus-1 constituents of the bark of Poncirus trifoliata.
Journal: Chemical & pharmaceutical bulletin 20100701
Title: A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Journal: Life sciences 20100327
Title: Colorectal cancer chemoprevention by 2 beta-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid.
Journal: International journal of cancer 20100215
Title: Auraptene from Ferula szowitsiana protects human peripheral lymphocytes against oxidative stress.
Journal: Phytotherapy research : PTR 20100101
Title: Suppression of CD74 expression and Helicobacter pylori adhesion by auraptene targeting serum starvation-activated ERK1/2 in NCI-N87 gastric carcinoma cells.
Journal: Bioscience, biotechnology, and biochemistry 20100101
Title: Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts.
Journal: BMC cancer 20100101
Title: Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.
Journal: BMC cancer 20100101
Title: Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents.
Journal: Bioorganic & medicinal chemistry letters 20090915
Title: Minor furanocoumarins and coumarins in grapefruit peel oil as inhibitors of human cytochrome P450 3A4.
Journal: Journal of natural products 20090901
Title: Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice.
Journal: Toxicology letters 20090328
Title: Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
Journal: Bioorganic & medicinal chemistry 20090101
Title: Chemoprevention with phytochemicals targeting inducible nitric oxide synthase.
Journal: Forum of nutrition 20090101
Title: Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats.
Journal: BMC cancer 20090101
Title: Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1.
Journal: European journal of pharmacology 20081214
Title: Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes.
Journal: Biochemical and biophysical research communications 20080201
Title: Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20080101
Title: Metabolism and absorption of auraptene (7-geranyloxylcoumarin) in male SD rats: comparison with 7-ethoxycoumarin.
Journal: Nutrition and cancer 20080101
Title: Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice.
Journal: Nutrition and cancer 20080101
Title: Auraptene, a citrus fruit compound, regulates gene expression as a PPARalpha agonist in HepG2 hepatocytes.
Journal: BioFactors (Oxford, England) 20080101
Title: Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade.
Journal: Carcinogenesis 20070601
Title: Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells.
Journal: Cancer science 20070401
Title: Citrus auraptene suppresses azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db mice.
Journal: Nutrition and cancer 20070101
Title: Citrus auraptene reduces Helicobacter pylori colonization of glandular stomach lesions in Mongolian gerbils.
Journal: Journal of oleo science 20070101
Title: Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA/1J mice: possible involvement of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis regulation.
Journal: BioFactors (Oxford, England) 20070101
Title: Auraptene decreases the activity of matrix metalloproteinases in dextran sulfate sodium-induced ulcerative colitis in ICR mice.
Journal: Bioscience, biotechnology, and biochemistry 20061201
Title: In vitro inhibitory activity of boropinic acid against Helicobacter pylori.
Journal: Bioorganic & medicinal chemistry letters 20061101
Title: Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism.
Journal: FEBS letters 20061002
Title: Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice.
Journal: International journal of cancer 20060615
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
Journal: Oncology reports 20050801
Title: [Chemical study of citrus plants in the search for cancer chemopreventive agents].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20050301
Title: Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20041201
Title: Synthesis and anti-inflammatory activity of natural and semisynthetic geranyloxycoumarins.
Journal: Bioorganic & medicinal chemistry letters 20040503
Title: Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
Journal: Oncology 20040101
Title: Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages.
Journal: Cancer letters 20030530
Title: Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel.
Journal: European journal of clinical pharmacology 20030201
Title: Rapid and convenient method for preparing aurapten-enriched product from hassaku peel oil: implications for cancer-preventive food additives.
Journal: Journal of agricultural and food chemistry 20020522
Title: Inhibition of acetylcholinesterase activity by essential oil from Citrus paradisi.
Journal: Natural product letters 20010101
Title: La VD, et al. Anti-inflammatory and wound healing potential of citrus auraptene. J Med Food. 2013 Oct;16(10):961-4.
